The Food and Drug Administration declined Friday to approve an application to treat post-traumatic stress disorder using the drug midomafetamine, also known as MDMA or the street drug ecstasy, citing ...

Forbes contributors publish independent expert analyses and insights. Sarah Sinclair is an award-winning journalist covering cannabis. Today, MDMA is probably best known as a “party drug,” more likely ...

TONIGHT, AND MAJOR MOVES ARE UNDERWAY SURROUNDING WHAT HAS BEEN A CONTROVERSIAL THERAPY FOR PTSD. THE USE OF PSYCHEDELICS WILL BE ON THE BALLOT IN NOVEMBER IN MASSACHUSETTS, AND THE FDA IS NOW ...

It has been 24 years since a pharmaceutical was last approved for posttraumatic stress disorder (PTSD). The condition is notoriously difficult to treat, with up to 40% patients finding no relief from ...

Experts highlight key risk factors for traumatic stress after childbirth and outline practical steps that clinicians can take ...